Hess, Heribert (Tecan 2012– Manager Commercial Operations D-A-CH) |
Sales Manager / Marketing Manager |
Tecan (Group) |
Germany |
Hess, Matthias (AnalytiCon Discovery 200504) |
n. a. |
BRAIN Biotech (Group) |
Germany |
Hess, René (Eppendorf 202209 Managing Director of DASGIP) |
Managing Director |
Eppendorf (Group) |
Germany |
Hessing, Michael |
n. a. |
Dr. Schmidt (Group) |
Germany |
Hesslein, Robert (Bob) (Voyager Therapeutics 201901– General Counsel before Foundation Medicine + Genzyme) |
General Counsel / Chief Legal Officer (CLO) |
Voyager Therapeutics Inc. (Nasdaq: VYGR) |
United States (USA) |
Hetke, Christian (Futalis GmbH 201111– Managing Director + Co-founder) |
Managing Director |
Futalis GmbH |
Germany |
Hettich, Andreas (Hettich Beteiligungen) |
n. a. |
Dr. Hettich Beiligungen GmbH (Andreas Hettich) |
Germany |
Hettich, Christof (Kanzlei Rittershaus + Dievini Hopp) |
Attorney / Lawyer |
Rittershaus Rechtsanwälte Partnerschaftsgesellschaft mbH |
Germany |
Heuer, Anja (Immatics 201907 Corporate Communications) |
Public Relations Manager / Investor Relations Manager |
Immatics (Group) |
Germany |
Heuer, Michael (Roche 201810– interim CEO of Roche Diagnostics before Region Head EMEA + Latin America joined BM 1983) |
Chief Executive Officer (CEO) |
Roche (Group) |
United States (USA) |
Heukamp, Wessel (Freshfields Bruckhaus Deringer 201610) |
Attorney / Lawyer |
Freshfields (Group) |
United Kingdom (GB) |
Heumann, Hermann (Silantes GmbH 201902 Managing Director) |
Managing Director |
Silantes GmbH |
|
Heumann, Klaus (Biomax 200611 CEO) |
Chief Executive Officer (CEO) |
Biomax (Group) |
Germany |
Heumann, Klaus (Univ Mainz 200701 Professor for Inorganic and Analytical Chemistry) |
Professor |
University of Mainz (Johannes Gutenberg University) |
Germany |
Heydler, Thomas P. (Definiens 200411– CEO) |
Chief Executive Officer (CEO) |
AstraZeneca (Group) |
Germany |
Heyne, Malte (Handelskammer Hamburg 202302 Managing Director (Hauptgeschäftsführer)) |
Managing Director |
Handelskammer Hamburg |
Germany |
Heyne, Wilfried (Humedics GmbH 201110 Managing Director) |
Managing Director |
Humedics GmbH |
Germany |
Heyse, Stephan (Genedata 200701 Head of Genedata Screener) |
Product Manager (personnel) |
Danaher (Group) |
Switzerland |
Heß, Markus (Astra Diagnostics 201105 Managing Director) |
Managing Director |
ADT Altona Diagnostic Technologies GmbH (Altona Diagnostics) |
Germany |
Heß, Rüdiger (PXBioVision 201104 Managing Director) |
Managing Director |
PXBioVisioN GmbH |
Germany |
Heßler, Nadine (JeNaCell GmbH 201210 Managing Director) |
Managing Director |
JeNaCell GmbH |
Germany |
Hibbs, Kathy L. (23andMe 202101 Chief Legal + Regulatory Officer before Genomic Health + Monogram Biosciences) |
General Counsel / Chief Legal Officer (CLO) |
23andMe Inc. |
United States (USA) |
Hickey, Dave (Siemens 200805 SVP Strategic Planning + BusDev at Siemens Healthcare Diagnostics) |
Business Development Manager / Strategy Manager |
Siemens (Group) |
Germany |
Hicks, Dave (Danaher 201004 VP + General Manager Pharmaceuticals + Proteomics at AB SCIEX) |
General Manager (management) |
Danaher (Group) |
Canada |
Higashi, Shunichi (Miraca 201808 CEO of Srl Inc) |
Chief Executive Officer (CEO) |
H.U. Group (Group) |
Japan |
Higgins, Arthur J. (Bayer HealthCare CEO 200407–201004 LEFT 4/10) |
Chief Executive Officer (CEO) |
Bayer (Group) |
Germany |
Higgins, John L. (Ligand –200710– President + CEO) |
Chief Executive Officer (CEO) |
Ligand (Group) |
United States (USA) |
High, Katharine (RhyGaze 202501 CEO formerly Spark Therapeutics) |
Chief Executive Officer (CEO) |
RhyGaze AG |
Switzerland |
Higham, Paul G. (Valo Therapeutics 202008– CEO before Glycotope + Immatics + Ark Therapeutics + GlaxoWellcome) |
Chief Executive Officer (CEO) |
Valo Therapeutics (Valo Tx) (Group) |
Finland |
Hilbert, Helmut (Curetis 201303– Head Business Development before Qiagen Business Development) |
Business Development Manager / Strategy Manager |
OpGen (Group) |
Germany |
Hilbrich, Lutz (Droege Investment 202409– CEO of Halix BV before ProBioGen AG + Sanofi China + Boehringer) |
Chief Executive Officer (CEO) |
Droege (Group) |
Netherlands |
Hildemann, Steven (Merck (DE) 201401– Global CMO at Merck Serono before MSD/Merck US) |
Chief Medical Officer (CMO) |
Merck (DE) (Group) |
Germany |
Hildinger, Markus (ExcellGene 200905 CBO) |
Chief Business Officer (CBO) |
ExcellGene S.A. |
Switzerland |
Hilfrich, Ralf (Abviris 2014– Managing Director + Co-Founder) |
Managing Director |
Abviris Deutschland GmbH |
Germany |
Hilgert, Lara (Gilde Investment, 202207– Investment Analyst at Gilde Healthcare in Ffm) |
Analyst (Financial / Industry) |
Gilde Investment (Group) |
Germany |
Hilkert, Andreas (Thermo Fisher 201512 Senior Manager Product Marketing Inorganic Mass Spectrometry) |
Product Manager (personnel) |
Thermo Fisher (Group) |
United States (USA) |
Hill, Adam M. (Oncimmune 201810– CEO joined 201803 before McLaren Applied Technologies) |
Chief Executive Officer (CEO) |
Freenome (Group) |
United Kingdom (GB) |
Hill, Adrian (Univ Oxford 201506 Professor + Director of Jenner Institute) |
Professor |
University of Oxford |
United Kingdom (GB) |
Hillebrand, Timo (Analytik Jena 201101 Managing Director AJ Innusreen GmbH) |
Managing Director |
IST Innuscreen GmbH |
Germany |
Hillenkamp, Franz (Univ Münster Prof, co-inventor MALDI-TOF MS) |
Professor |
University of Münster (Westfälische Wilhelms-Universität Münster) |
Germany |
Hillgrove, Allan (Boehringer 201301– promoted Managing Director Div Marketing + Sales Prescription Medicines) |
Managing Director |
Boehringer Ingelheim (Group) |
Germany |
Hillisch, Alexander (Bayer HealthCare AG 200508) |
n. a. |
Bayer (Group) |
Germany |
Hils, Martin (Zedira 201106 CEO + co-founder before N-Zyme Biotec) |
Managing Director |
Zedira GmbH |
Germany |
Hilterhaus, Dierk (Xtal Concepts 201208 Managing Director) |
Managing Director |
Xtal Concepts GmbH |
Germany |
Hilvert, Donald (ETH Zürich 201310 Professor at Lab for Organic Chemistry) |
Professor |
ETH Zürich (ETHZ) |
Switzerland |
Himmler, Gottfried (f-star 200709 CEO + co-founder) |
Chief Executive Officer (CEO) |
Sino Biopharm (Group) |
Austria |
Hing, Paul (Sensovation 201110 CTO) |
Chief Technology/Technical Officer (CTO) |
Miltenyi Biotec (Group) |
Germany |
Hingst, Thomas (Logic Works 2001– Managing Director + Co-founder) |
Managing Director |
Logic Works GmbH |
Germany |
Hinterding, Klaus (Proteros 201202– CSO before Roche + Novartis) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Proteros (Group) |
Germany |
Hintsche, Rainer (2000– eBiochip Systems founder + Managing Director) |
Managing Director |
Endress+Hauser (Group) |
Germany |
Hinz, Julia (Potsdam Science Park 202305 Location Marketing) |
Sales Manager / Marketing Manager |
Potsdam Science Park (Standortmanagement Golm GmbH) |
Germany |
Hinze, Andrea (Immunic 202401 Social Media + PR Manager) |
Public Relations Manager / Investor Relations Manager |
Immunic (Group) |
Germany |
Hinzen, Berthold (Bayer 201003 Head Global BusDev + Licensing General Medicine) |
Business Development Manager / Strategy Manager |
Bayer (Group) |
Germany |
Hinzen, Dieter (BI 200409) |
n. a. |
Boehringer Ingelheim (Group) |
Germany |
Hippe, Alan (Roche 201104– CFO before ThyssenKrupp + Continental + Fraport) |
Chief Financial Officer (CFO) |
Roche (Group) |
Switzerland |
Hippolyte, Christopher (Ruth Group 201612) |
Public Relations Manager / Investor Relations Manager |
Ruth Group, The (TRG) |
United States (USA) |
Hirano, Hiro (KKR 201506 Head KKR Japan) |
President/Director/Head Business Group/Unit/Division |
KKR (Kohlberg Kravis Roberts) (Group) |
United States (USA) |
Hirashima, Shoji (Daiichi Sankyo 201302 Managing Director of U3 Pharma GmbH) |
Managing Director |
Daiichi Sankyo (Group) |
Germany |
Hirawat, Samit (BMS 202108 CMO before Novartis 201710 EVP + Head Global Drug Development at Novartis Oncology) |
Chief Medical Officer (CMO) |
Bristol Myers Squibb (BMS) (Group) |
United States (USA) |
Hirner (Mandt), Denise (UpNano 202212 COO + Co-Founder) |
Chief Operating Officer (COO) |
UpNano GmbH |
Austria |
Hirsbrunner, Fritz (Galenica –201112 CFO + Deputy CEO ) |
Chief Financial Officer (CFO) |
Galenica (Group) |
Switzerland |
Hirsch, Christian (Showa Denko 202004 General Manager Shodex Business EMEA at Showa Denko Europe GmbH) |
General Manager (management) |
Resonac (Group) |
Germany |
Hirsch, David (Alpha-9 Oncology 202401 CEO + Longitude Capital 201811 Managing Director + Founder) |
Chief Executive Officer (CEO) |
Alpha-9 Oncology (Group) |
Canada |
Hirsch, Didier (Agilent 201007–201810 CFO at Agilent since 1999 before HP since 1989 RETIRED 10/18) |
Chief Financial Officer (CFO) |
Agilent (Group) |
United States (USA) |
Hirsch, Hans (Co.faktor 202309 Business Development Consulttant) |
Business Development Manager / Strategy Manager |
Cytel (Group) |
Germany |
Hirsch, Hendrik (CMS 201408 Partner at CMS Hasche Sigle Ffm) |
Attorney / Lawyer |
CMS (Group) |
Germany |
Hirsch, Volker (United Kingdom (govt) 202210– CCO at Medicines Discovery Catapult before Amadeus Capital) |
Chief Commercial Officer (CCO) |
United Kingdom (GB) (govt) |
United Kingdom (GB) |
Hirse, Thomas (CMS Hasche Sigle 2007 Attorney at CMS Hasche Sigle Düsseldorf before Linklaters LLP Köln) |
Attorney / Lawyer |
CMS (Group) |
Germany |
Hirst, Simon (Sygnature Discovery 201112 CEO + Founder) |
Chief Executive Officer (CEO) |
Sygnature Discovery (Group) |
United Kingdom (GB) |
Hiruta, Kazuyuki (20170823 CEO of Icon Genetics GmbH) |
Managing Director |
Denka (Group) |
Germany |
Hitchcock, Marion (Bayer 202005 Strategic Alliance Manager at Bayer Pharmaceuticals) |
Business Development Manager / Strategy Manager |
Bayer (Group) |
United States (USA) |
Hitchcock, Steven (Takeda 201909 Global Head of Research) |
Research & Development Manager |
Takeda (Group) |
Japan |
Hittinger, Marius (MucosaTec 202407 CEO) |
Chief Executive Officer (CEO) |
Mucosatec (DE) |
Germany |
Hjortsmark, Maria (Gyros 201307 Global Marketing Director before Halo Genomics CBO) |
Sales Manager / Marketing Manager |
Mesa Laboratories (Mesa Labs) (Group) |
Sweden |
Ho, Peter T. C. (Boston Pharmaceuticals before Epizyme + BeiGene + GSK + DuPont + Novartis) |
Business Development Manager / Strategy Manager |
BERTARELLI Group (family of Ernesto Bertarelli) |
United States (USA) |
Ho, Selwyn (Medigene 202207– CEO before Connect Biopharma) |
Chief Executive Officer (CEO) |
Medigene (Group) |
Germany |
Ho, Tony (CRISPR Therapeutics 201708– EVP + Head RnD) |
n. a. |
CRISPR Therapeutics (Group) |
Switzerland |
Hobbs, Eric D. (Berkeley Lights 202203– President of Antibody Therapetuics business before CEO) |
President/Director/Head Business Group/Unit/Division |
Bruker (Group) |
United States (USA) |
Hobe, Herr (Intavis 200809) |
Sales Manager / Marketing Manager |
HB Technologies (Group) |
Germany |
Hobmeier, Mike (Verve Capital Partners 202206) |
n. a. |
Verve Capital Partners AG (Verve Ventures, formerly investiere.ch) |
Switzerland |
Hoch, Erich (Körber 202501– Group Executive Board Member + President Business Area Pharma) |
Board member, executive |
Körber (Group) |
Germany |
Hoch, Thomas (EVP Capital 201106 Executive Board Director) |
Board member, executive |
EVP Capital Management AG |
Germany |
Hochmair, Erwin (MED-EL Co-Founder) |
Company Founder |
MED-EL Elektromedizinische Geräte GmbH |
Austria |
Hochmair, Ingeborg (MED-EL 201611 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
MED-EL Elektromedizinische Geräte GmbH |
Austria |
Hochstrasser, Denis (University Geneva 201005 Professor HUG Head Dept Genetic and Laboratory Medicine) |
Professor |
University of Geneva (Université de Genève, UNIGE) |
Switzerland |
Hochuli, Tom (Vibalogics 202009– CEO before Lonza Houston) |
Chief Executive Officer (CEO) |
Recipharm (Group) |
Germany |
Hochwimmer, Georg (SmartDyeLivery GmbH 20602 Managing Director) |
Managing Director |
SmartDyeLivery GmbH |
Germany |
Hock, Björn (Merck (DE) 201507 Global Head Protein Engineering + Antibody Technologies at Merck Sereno) |
President/Director/Head Business Group/Unit/Division |
Merck (DE) (Group) |
Germany |
Hock, Christoph (Neurimmune 201808– CMO before Co-Founder + Board Member main org Univ Zurich) |
Chief Medical Officer (CMO) |
Neurimmune AG |
Switzerland |
Hockley, Christine (United Kingdom (govt) 202402 Managing Director for Funds at British Patient Capital) |
Managing Director |
United Kingdom (GB) (govt) |
United Kingdom (GB) |
Hodel, Svenja (Life Science Factory 202207 Communication Manager) |
Public Relations Manager / Investor Relations Manager |
Sartorius (Group) |
Germany |
Hodits, Regina (Wellington Partners 201101– General Partner before part-time advisor before Atlas Venture until 201001) |
General Partner (venture partner) |
Wellington Partners (Group) |
Germany |
Hoefer, Eric (Arcus Biosciences 201906– CCO before AstraZeneca + Roche/Genentech + Glaxo Wellcome) |
Chief Commercial Officer (CCO) |
Arcus Biosciences Inc. (NYSE: RCUS) |
United States (USA) |
Hoehnel, Sylke (Sun Bioscience 202310 Co-CEO + Co-Founder) |
Chief Executive Officer (CEO) |
|
Switzerland |
Hoem, Jon H. (Miracor 200806– CEO) |
Chief Executive Officer (CEO) |
Miracor (Group) |
Austria |
Hoenlinger, Sheida (SGS 201610 Director Life Sciences Germany) |
President/Director/Head Business Group/Unit/Division |
SGS (Group) |
Switzerland |
Hoerr, Ingmar (CureVac 201806– Chairman of Supervisory Board before 2000–201806 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
CureVac (Group) |
Germany |
Hoess, Adi (Affimed 201109– CEO before CCO before Jenowis + Jerini 2003– + Carl Zeiss AG + MorphoSys AG) |
Chief Executive Officer (CEO) |
Affimed (Group) |
Germany |
Hof, Catherine (Polyphor 201608 Corporate Communications) |
Public Relations Manager / Investor Relations Manager |
Spexis (Group) |
Switzerland |
Hofacher, Werner (Orgentec 201506 CEO) |
Chief Executive Officer (CEO) |
Orgentec (Group) |
Germany |